Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus

doi:10.3748/wjg.v23.i43.7735

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 43

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8864)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

560

WORD

183

HTML

4456

Figures (1-4)

320

Tables (1-4)

282

Sum=5801

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1101

Download

1962

Sum=3063

Nov 21, 2017 (publication date) through Jan 8, 2025

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Nov 21, 2017; 23(43): 7735-7745
Published online Nov 21, 2017. doi: 10.3748/wjg.v23.i43.7735

Full Size Figure Download Figure

Figure 4 Overall survival of the overall cohort and matched cohort. A: Kaplan-Meier curves for the overall patient cohort. OS differed between the two groups (OS, 12.3 vs 5.2 mo; P < 0.001); B: Kaplan-Meier curves for disease free survival in the overall patient cohort. C: Kaplan-Meier curves for OS in propensity score-matched patiens. Median OS was longer in group A than in group B (10.3 vs 6.0 mo; P < 0.001); D: Kaplan-Meier curves for disease free survival in propensity score-matched

Citation: Zhang ZH, Liu QX, Zhang W, Ma JQ, Wang JH, Luo JJ, Liu LX, Yan ZP. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus. World J Gastroenterol 2017; 23(43): 7735-7745
URL: https://www.wjgnet.com/1007-9327/full/v23/i43/7735.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i43.7735